HSE seeks ‘flexibility’ on use of Johnson & Johnson jabs for under-50s

Paul Reid, chief executive of the HSE (Brian Lawless/PA)

The HSE has asked for “flexibility” to allow the use of the Johnson & Johnson vaccine, also known as the Janssen vaccine, for people aged under 50.

It follows a recommendation from the National Immunisation Advisory Committee (NIAC) that the Johnson & Johnson and AstraZeneca jabs not be given to people under 50.